A pioneering approach to imaging breast cancer in mice has revealed new clues about why the human immune system often fails to attack tumors and keep cancer in check. This observation, by scientists at the University of California, San Francisco (UCSF), may help to reveal new approaches to cancer immunotherapy.

In a study of patients 65 and older with non-small-cell lung cancer (NSCLC), younger patients were more likely to receive treatment than older patients, regardless of overall health and prognosis.

UCSF Chancellor Susan Desmond-Hellmann, MD, MPH, announced a four-year $100 million fund-raising initiative during her April 24 speech marking the beginning of commencement season at the University.

A new brain cancer vaccine tailored to individual patients by using material from their own tumors has proven effective in a multicenter phase 2 clinical trial at extending their lives by several months or longer. The patients suffered from recurrent glioblastoma multiforme—which kills thousands of Americans every year.

The key to treating one of the most common types of human leukemia may lie within mutations in a gene called FLT3, according to new research led by physician-scientists at the University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center.

Frank McCormick, PhD, FRS, director of the Helen Diller Family Comprehensive Cancer Center at UCSF, was elected president of the 35,000-member American Association of Cancer Research (AACR), the world’s largest organization of its kind dedicated to prevent and cure cancer through research, education, communication and collaboration.

Breast cancer survivor Helen Robillard closes her eyes as she gently rotates her arms clockwise. Her movements are measured and deliberate; her breathing slow and purposeful.

Scientists have gained insight into how second-hand tobacco smoke damages the earliest stages of human embryonic development.

Onsemble, the user community for OnCore, UCSF’s new enterprise wide Clinical Research Informatics System, is comprised of over 40 Academic Centers and Stand Alone Premier hospitals, including the majority of NCI Designated Cancer Centers, which includes other University of California campuses.

Simultaneous targeting of two different molecules in cancer is an effective way to shrink tumors, block invasion, and stop metastasis, scientists at the University of California, San Francisco (UCSF) have found — work that may improve the effectiveness of combination treatments that include drugs like Avastin.